Hospitals - Switzerland

Switzerland

In Switzerland, the Hospitals market is predicted to witness a significant growth in revenue, with projections indicating that it will reach US$39.75bn in 2024.
Furthermore, it is expected that the market will continue to expand at an annual growth rate of 3.77% (CAGR 2024-2029), leading to a market volume of US$47.82bn by 2029.
When compared to other countries globally, it is worth noting that United States is expected to generate the highest revenue in the Hospitals market, with a staggering US$1,501.00bn in 2024.
In terms of per capita revenue, in Switzerland is projected to generate US$4.49k per person in the year 2024.
This figure reflects the revenue generated in relation to the country's total population.
Switzerland's hospitals are renowned for their efficient and well-equipped facilities, attracting patients from around the world.

Key regions: United States, China, Germany, Japan, Europe

Market

Region

Region comparison

Currency

Analyst Opinion

Switzerland is known for its high-quality healthcare system, and the Hospitals market is no exception.

Customer preferences: Swiss customers prefer hospitals that offer personalized and high-quality care. They value hospitals with state-of-the-art medical equipment and facilities. Patients in Switzerland also prioritize hospitals that offer a wide range of medical specialties and treatments.

Trends in the market: The Hospitals market in Switzerland is experiencing an increase in demand due to the aging population and rising chronic illnesses. This trend is expected to continue in the coming years. In response, hospitals are investing in new medical technologies and expanding their services to meet the growing demand. Additionally, there is a trend towards outpatient care, with more patients opting for day surgeries and treatments. This has led to an increase in specialized clinics and outpatient facilities.

Local special circumstances: Switzerland has a decentralized healthcare system, with each canton (state) responsible for its healthcare policies and funding. This has led to a diverse range of hospital systems and services across the country. Additionally, Switzerland has a high number of private hospitals, which can be expensive for patients without adequate insurance coverage. The country's strong economy and high standard of living have also contributed to the growth of the Hospitals market.

Underlying macroeconomic factors: Switzerland's healthcare system is heavily regulated, with strict quality standards and high levels of government spending. The country has a strong focus on research and development, which has led to the development of new medical technologies and treatments. Additionally, Switzerland has a highly skilled workforce, with many healthcare professionals trained in the country's top universities and hospitals. The country's political stability and strong financial sector have also contributed to the growth of the Hospitals market.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on revenue received by hospitals from public or private sources, allocated to the country where the money is spent, including VAT if applicable.

Modeling approach / Market size:

Market sizes are determined by a bottom-up approach, based on a specific rationale for each market market. Next, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, public health spend, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.